BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25895391)

  • 21. Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: evidence from clinic to laboratory.
    Liu L; Li J; Zhang Y; Zhang S; Ye J; Wen Z; Ding J; Kunapuli SP; Luo X; Ding Z
    Thromb Res; 2014 Oct; 134(4):866-76. PubMed ID: 25077998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the antithrombotic activity of Zhi-Xiong Capsules, a Traditional Chinese Medicinal formula, via the pathway of anti-coagulation, anti-platelet activation and anti-fibrinolysis.
    Zhou J; Song Z; Han M; Yu B; Lv G; Han N; Liu Z; Yin J
    Biomed Pharmacother; 2018 Jan; 97():1622-1631. PubMed ID: 29793324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
    Song Q; Wang S; Zhao W
    J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compound Danshen Dripping Pill inhibits high altitude-induced hypoxic damage by suppressing oxidative stress and inflammatory responses.
    Hu Y; Sun J; Wang T; Wang H; Zhao C; Wang W; Yan K; Yan X; Sun H
    Pharm Biol; 2021 Dec; 59(1):1585-1593. PubMed ID: 34808069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation Procoagulant Activity and Mechanism of Astragalin.
    Li C; Hu M; Jiang S; Liang Z; Wang J; Liu Z; Wang HD; Kang W
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31906332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Bak Foong Pill on blood coagulation and platelet aggregation.
    Gou YL; Ho AL; Rowlands DK; Chung YW; Chan HC
    Biol Pharm Bull; 2003 Feb; 26(2):241-6. PubMed ID: 12576687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic effect of a factor Xa inhibitor, TAK-442, and antiplatelet agents on whole blood coagulation and arterial thrombosis in rats.
    Konishi N; Hiroe K; Kawamura M
    Thromb Res; 2010 Aug; 126(2):124-9. PubMed ID: 20452654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
    Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
    Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of antiplatelet effect and tolerability of clopidogrel resinate with clopidogrel bisulfate in patients with coronary heart disease (CHD) or CHD-equivalent risks: a phase IV, prospective, double-dummy, parallel-group, 4-week noninferiority trial.
    Suh JW; Seung KB; Gwak CH; Kim KS; Hong SJ; Park TH; Kim SH; Choi YJ; Joo SJ; Tahk SJ; Kim HS
    Clin Ther; 2011 Aug; 33(8):1057-68. PubMed ID: 21816478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
    Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative research on pharmacodynamics of Danshen co-microemulsion on hemorheology in rats with hyperlipidemia].
    Ji HS; Yu F; Yang J
    Zhong Yao Cai; 2008 Apr; 31(4):566-9. PubMed ID: 18661833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
    Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
    Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of Clopidogrel on Pharmacokinetic of Fufang Danshen Dripping Pill (FDDP)].
    Ma ST; Dai GL; Sun BT; Zhao WZ; Ju WZ; Tan HS
    Zhong Yao Cai; 2014 Dec; 37(12):2240-3. PubMed ID: 26080512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K/AKT and PPAR signaling pathways.
    Lei W; Li X; Li L; Huang M; Cao Y; Sun X; Jiang M; Zhang B; Zhang H
    J Ethnopharmacol; 2021 Dec; 281():114438. PubMed ID: 34390798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research of the dynamic regulatory mechanism of Compound Danshen Dripping Pills on myocardial infarction based on metabolic trajectory analysis.
    Zhang CJ; Qu XY; Yu ZY; Yang J; Zhu B; Zhong LY; Sun J; He JH; Zhu YX; Dong L; Xu WJ
    Phytomedicine; 2024 Jul; 130():155626. PubMed ID: 38850631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition.
    Björkman JA; Zachrisson H; Forsberg GB; von Bahr H; Hansson GI; Warner TD; Nylander S
    Thromb Res; 2013 Apr; 131(4):313-9. PubMed ID: 23419412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
    Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
    Reiner MF; Akhmedov A; Stivala S; Keller S; Gaul DS; Bonetti NR; Savarese G; Glanzmann M; Zhu C; Ruf W; Yang Z; Matter CM; Lüscher TF; Camici GG; Beer JH
    Cardiovasc Res; 2017 Jan; 113(1):61-69. PubMed ID: 28028070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
    Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
    Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iridoid glycosides extracted from zhizi (fructus gardeniae) decrease collagen-induced platelet aggregation and reduce carotid artery thrombosis in an in vivo rat model.
    Wang P; Wang Q; Luo C; Tan C; Yuan X
    J Tradit Chin Med; 2013 Aug; 33(4):531-4. PubMed ID: 24187877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.